NEWSROOM
MEDIA
ABBOTT INDIA LTD
PRODUCTS
CAREERS
ABOUT ABBOTT
BUSINESS AREAS
THERAPY AREAS
FOR PROFESSIONALS
Abbott in India develops and distributes over 600 products for healthcare professionals that promote health and well-being for Indians in all stages of life. Search by all products, business area or pharmaceutical therapy area below.
Business: Abbott Healthcare Solutions
MOLECULE: Gliclazide B.P. and Metformin HCI I.P.
FORM: Tablet
STRENGTH: Gliclazide B.P. 30 mg + Metformin HCI I.P. 500 mg
BUSINESS AREAS: PHARMACEUTICALS
THERAPY AREAS: CARDIO-DIABETO
STRENGTH: Gliclazide B.P. 60 mg + Metformin HCI I.P. 500 mg
MOLECULE: Ceftazidime and Tazobactum sodium
FORM: Injection
STRENGTH: Ceftazidime 1gm + Tazobactum sodium 125mg
THERAPY AREAS: ANTI-INFECTIVES
Business: Abbott Truecare
MOLECULE: Cefpodoxime + Clavulanic acid
FORM: Dispersible Tablet
STRENGTH: Cefpodoxime 100 mg + Clavulanic acid 62.5 mg
FORM: Dry Syrup
STRENGTH: Cefpodoxime 50 mg + Clavulanic acid 31.25 mg / 5ml
STRENGTH: Cefpodoxime 200 mg + Clavulanic acid 125 mg
MOLECULE: Cefpodoxime + Ofloxacin
STRENGTH: Cefpodoxime 200 mg + Ofloxacin 200 mg
MOLECULE: Cefpodoxime Proxetil
STRENGTH: 50mg; 100mg
STRENGTH: 50mg/5ml
STRENGTH: 200mg Modified release
MOLECULE: Cefixime + Azithromycin
STRENGTH: Cefixime 200 mg + Azithromycin 250 mg
STRENGTH: Cefixime 100 mg + Azithromycin 125 mg
STRENGTH: Cefixime 200 mg + Azithromycin 500 mg
MOLECULE: Cefixime + Clavulanic acid
STRENGTH: Cefixime 100 mg + Clavulanic acid 62.5 mg
STRENGTH: Cefixime 50 mg + Clavulanic acid 31.25 mg / 5ml
STRENGTH: Cefixime 200 mg + Clavulanic acid 125 mg
MOLECULE: Cefixime + Dicloxacillin + Lactic Acid Bacillus
STRENGTH: Cefixime 200 mg + Dicloxacillin 500 mg ER + Lactic Acid Bacillus 90 million spores
MOLECULE: Cefixime + Ofloxacin
STRENGTH: Cefixime 100 mg + Ofloxacin 100 mg DT; Cefixime 200 mg + Ofloxacin 200 mg
MOLECULE: Cefixime
STRENGTH: 50mg / 5ml
FORM: Readymix
STRENGTH: Readymix
STRENGTH: 200mg
MOLECULE: Diclofenac free acid
STRENGTH: Diclofenac free acid 46.5mg(Equivalent to Diclofenac Sodium IP 50 mg)
THERAPY AREAS: PAIN MGMT
MOLECULE: Diclofenac sodium IP (Sustained Release)
STRENGTH: 100 mg
MOLECULE: Diclofenac sodium IP, Benzyl Alcohol IP, Water for injection I.P. q.s.
STRENGTH: Diclofenac sodium IP 25mg + Benzyl Alcohol IP 40 mg, Water for injection I.P. q.s.
MOLECULE: Zoledronic acid,Mannitol and Sodium citrate
STRENGTH: Zoledronic acid 5 mg + Mannitol 4950 mg + Sodium citrate 30 mg
Business: Abbott India Limited
MOLECULE: Zolpidem Tartrate
STRENGTH: 12.5 MG, 6.25 MG
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,GENNEXT
THERAPY AREAS: GENNEXT
STRENGTH: 5 mg; 10mg
BUSINESS AREAS: PHARMACEUTICALS,PHARMACEUTICALS ABBOTT INDIA LIMITED,GENNEXT
THERAPY AREAS: NEURO-PSYCHIAT,GENNEXT
MOLECULE: Colistimethate Sodium BP
STRENGTH: Colistimethate Sodium BP 20,00,000 IU (IU: International Units)
STRENGTH: Colistimethate Sodium BP 10,00,000 IU (IU: International Units)
MOLECULE: Vildagliptin and Metformin hydrochloride
STRENGTH: Vildagliptin 50 mg + Metformin hydrochloride Ph. Eur. 1000 mg
STRENGTH: Vildagliptin 50 mg + Metformin hydrochloride Ph. Eur. 500 mg
STRENGTH: Vildagliptin 50 mg + Metformin hydrochloride Ph. Eur. 850 mg
MOLECULE: Vildagliptin
STRENGTH: 50 mg
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimized for your screen size.
Asset Warning